Month: October 2019

Critical Mistakes to Avoid During a Pharmaceutical Drug Launch

Introduction Bringing a new pharmaceutical drug to market is an endeavor of immense complexity and significant financial investment, often spanning […]

Critical Mistakes to Avoid During a Pharmaceutical Drug Launch Read Post »

The Grand Bargain: How the Hatch-Waxman Act Forged the Modern Generic Drug Industry and Unleashed a Four-Decade War for the American Pill Bottle

Introduction: The Grand Bargain That Forged an Industry and a Battlefield In the annals of American industrial policy, few pieces

The Grand Bargain: How the Hatch-Waxman Act Forged the Modern Generic Drug Industry and Unleashed a Four-Decade War for the American Pill Bottle Read Post »

The Pre-Approval Playbook: How to Identify Generic Entrants and Turn Data into Dominance

In the high-stakes world of pharmaceuticals, the transition from a branded drug monopoly to a competitive generic market is one

clinical trials to identify 505(b)(2) launches

The Pre-Approval Playbook: How to Identify Generic Entrants and Turn Data into Dominance Read Post »

October 2019

Critical Mistakes to Avoid During a Pharmaceutical Drug Launch

The Grand Bargain: How the Hatch-Waxman Act Forged the Modern Generic Drug Industry and Unleashed a Four-Decade War for the American Pill Bottle

The Pre-Approval Playbook: How to Identify Generic Entrants and Turn Data into Dominance

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!